跳至主要内容
临床试验/NCT02358525
NCT02358525已完成不适用

Effects of a Multi-Modality Rehabilitation Program on Immune Activation, Depressive Symptoms and Quality of Life in Heart Failure Patients. A Pilot Study

Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
试验地点
2
主要终点
inflammatory activity

研究概览

简要总结

The aim of this descriptive study is to examine potential changes regarding inflammatory cytokine levels, depressive symptoms and quality of life over the course of the 4-week inpatient rehabilitation program which includes a cassette of modalities including counseling, psychosocial education and supervised exercise training as a main pillar, and to further investigate if there are correlations between changes in immune regulation, depressive symptoms and quality of life.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of heart failure with reduced ejection fraction (HFREF) with an EF ≤ 45%, NYHA (New York Heart Association) I - III; ACC/AHA (American College of Cariology/ American Heart Association) stage C, irrespective of etiology
  • Clinically stable patients without deterioration or hospitalization due to heart failure within the last 4 weeks
  • Neuro-hormonal medication according to the ESC (European Society of Cardiology) guidelines for the treatment of chronic heart failure consisting of antagonists of the Renin-Angiotensin-Aldosterone System (RAAS) and beta-blockers as indicated.
  • Ability to fully understand all elements of and sign the written informed consent before initiation of the study

排除标准

  • Fluid retention of cardiac decompensation, necessitating i.v. diuretic therapy
  • Myocardial infarction within the last 2 months
  • Surgery including cardiovascular or valvular surgery within 3 Months
  • Uncontrolled proinflammatory comorbidities (e.g. Diabetes mellitus HbA1c >9%, COPD ( chronic obstructive pulmonary disease) >II, active rheumatic diseases and autoimmune disorders)
  • Current infectious diseases ( e.g. pneumonia, COPD exacerbations or urinary tract infections)
  • Morbid obesity: BMI > 40
  • Alcohol or drug abuse
  • psychiatric disorders

结局指标

主要结局

inflammatory activity

时间窗: 8 weeks

levels of inflammatory biomarkers: Interleukin - 6, Tumor Necrosis Factor-alpha, Interleukin-1beta, Cellular Adhesion Molecule-1

次要结局

  • Quality of Life(8 weeks)
  • physical fitness(8 weeks)
  • Depressive Symptoms(8 weeks)

研究者

发起方
Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Katherine Wachmann

Study coordinator

Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation

研究点 (2)

Loading locations...

相似试验